Stock listing
KRX:145720 Dentium Co., Ltd. (덴티움) 주가
Follow Dentium Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:145720
₩39,500 KRW -300 (-0.8%)
Close on Nov 20, 2026
- Day range
- ₩38,900 – ₩41,000 KRWNov 20, 2026
- Volume
- 23,719 sharesNov 20, 2026
- Market cap
- ₩326.5B KRWAt the close on Nov 20, 2026 · price × 8.26M shares outstanding
- 52-week range
- ₩35,000 – ₩57,300 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩744.1M KRWMedian day 16,627 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:145720 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩39,500 | -300 | -0.8% | ₩40,000 | ₩41,000 | ₩38,900 | 23,719 | |
| ₩39,800 | +300 | +0.8% | ₩39,550 | ₩40,200 | ₩39,300 | 20,467 | |
| ₩39,500 | +650 | +1.7% | ₩39,150 | ₩40,650 | ₩38,600 | 40,729 | |
| ₩38,850 | +1,700 | +4.6% | ₩37,600 | ₩39,550 | ₩37,150 | 45,538 | |
| ₩37,150 | -850 | -2.2% | ₩38,050 | ₩38,250 | ₩37,100 | 31,445 | |
| ₩38,000 | -1,050 | -2.7% | ₩39,100 | ₩39,650 | ₩37,750 | 22,296 | |
| ₩39,050 | -450 | -1.1% | ₩39,000 | ₩39,500 | ₩38,400 | 24,202 | |
| ₩39,500 | +600 | +1.5% | ₩39,300 | ₩39,750 | ₩39,100 | 20,786 | |
| ₩38,900 | -50 | -0.1% | ₩38,700 | ₩39,650 | ₩38,650 | 22,255 | |
| ₩38,950 | -850 | -2.1% | ₩37,650 | ₩39,500 | ₩37,300 | 16,600 | |
| ₩39,800 | +150 | +0.4% | ₩39,700 | ₩40,800 | ₩39,500 | 16,331 | |
| ₩39,650 | +150 | +0.4% | ₩39,650 | ₩40,000 | ₩38,600 | 16,484 | |
| ₩39,500 | -450 | -1.1% | ₩39,750 | ₩40,000 | ₩38,900 | 10,680 | |
| ₩39,950 | -400 | -1.0% | ₩39,300 | ₩40,000 | ₩38,450 | 14,741 | |
| ₩40,350 | +600 | +1.5% | ₩39,450 | ₩40,650 | ₩39,400 | 33,000 | |
| ₩39,750 | -150 | -0.4% | ₩40,300 | ₩40,500 | ₩39,550 | 34,093 | |
| ₩39,900 | +1,100 | +2.8% | ₩39,000 | ₩40,350 | ₩39,000 | 29,215 | |
| ₩38,800 | -100 | -0.3% | ₩38,950 | ₩39,300 | ₩37,950 | 30,056 | |
| ₩38,900 | -1,800 | -4.4% | ₩40,800 | ₩40,800 | ₩38,750 | 24,620 | |
| ₩40,700 | +1,200 | +3.0% | ₩39,400 | ₩40,850 | ₩39,250 | 52,372 | |
| ₩39,500 | -150 | -0.4% | ₩39,800 | ₩40,300 | ₩39,200 | 22,308 | |
| ₩39,650 | +900 | +2.3% | ₩39,500 | ₩39,950 | ₩38,850 | 19,517 | |
| ₩38,750 | -300 | -0.8% | ₩39,050 | ₩40,000 | ₩38,700 | 17,250 | |
| ₩39,050 | -350 | -0.9% | ₩37,950 | ₩39,050 | ₩37,950 | 8,556 | |
| ₩39,400 | +1,900 | +5.1% | ₩38,550 | ₩40,200 | ₩38,450 | 37,832 | |
| ₩37,500 | -1,800 | -4.6% | ₩38,500 | ₩38,500 | ₩37,200 | 17,942 | |
| ₩39,300 | 0 | 0.0% | ₩39,450 | ₩40,000 | ₩38,550 | 16,654 | |
| ₩39,300 | +700 | +1.8% | ₩38,800 | ₩39,550 | ₩37,800 | 39,452 | |
| ₩38,600 | -1,750 | -4.3% | ₩40,000 | ₩40,000 | ₩38,500 | 17,508 | |
| ₩40,350 | +350 | +0.9% | ₩40,200 | ₩40,900 | ₩40,050 | 33,386 | |
| ₩40,000 | -350 | -0.9% | ₩40,100 | ₩40,450 | ₩39,700 | 17,850 | |
| ₩40,350 | +1,600 | +4.1% | ₩39,400 | ₩40,450 | ₩39,300 | 44,377 | |
| ₩38,750 | +1,650 | +4.4% | ₩38,250 | ₩39,100 | ₩37,850 | 24,257 | |
| ₩37,100 | +600 | +1.6% | ₩36,900 | ₩37,150 | ₩36,500 | 4,937 | |
| ₩36,500 | -150 | -0.4% | ₩36,700 | ₩36,950 | ₩36,400 | 7,108 | |
| ₩36,650 | -550 | -1.5% | ₩37,000 | ₩37,250 | ₩36,000 | 12,164 | |
| ₩37,200 | +600 | +1.6% | ₩36,450 | ₩37,300 | ₩36,350 | 9,131 | |
| ₩36,600 | -700 | -1.9% | ₩37,500 | ₩37,600 | ₩36,600 | 9,744 | |
| ₩37,300 | -100 | -0.3% | ₩37,500 | ₩37,900 | ₩37,300 | 7,608 | |
| ₩37,400 | -800 | -2.1% | ₩38,000 | ₩38,050 | ₩37,350 | 9,449 | |
| ₩38,200 | +650 | +1.7% | ₩37,850 | ₩38,900 | ₩37,600 | 16,459 | |
| ₩37,550 | 0 | 0.0% | ₩37,550 | ₩37,550 | ₩37,100 | 5,984 | |
| ₩37,550 | +250 | +0.7% | ₩37,100 | ₩37,900 | ₩36,950 | 11,783 | |
| ₩37,300 | -700 | -1.8% | ₩37,750 | ₩38,200 | ₩37,000 | 7,459 | |
| ₩38,000 | +150 | +0.4% | ₩38,000 | ₩38,200 | ₩37,000 | 12,880 | |
| ₩37,850 | +1,050 | +2.9% | ₩37,000 | ₩37,900 | ₩36,650 | 13,847 | |
| ₩36,800 | -700 | -1.9% | ₩37,500 | ₩37,500 | ₩36,750 | 19,186 | |
| ₩37,500 | +300 | +0.8% | ₩37,300 | ₩38,050 | ₩37,200 | 9,513 | |
| ₩37,200 | -850 | -2.2% | ₩38,250 | ₩38,450 | ₩37,100 | 11,774 | |
| ₩38,050 | +500 | +1.3% | ₩38,100 | ₩38,200 | ₩37,700 | 4,788 | |
| ₩37,550 | +300 | +0.8% | ₩37,900 | ₩38,000 | ₩37,300 | 8,942 | |
| ₩37,250 | +550 | +1.5% | ₩36,850 | ₩37,650 | ₩36,700 | 16,474 | |
| ₩36,700 | -650 | -1.7% | ₩36,950 | ₩37,450 | ₩36,450 | 9,178 | |
| ₩37,350 | -50 | -0.1% | ₩37,500 | ₩37,500 | ₩36,900 | 11,590 | |
| ₩37,400 | -800 | -2.1% | ₩37,700 | ₩37,750 | ₩36,550 | 13,333 | |
| ₩38,200 | +1,100 | +3.0% | ₩37,150 | ₩38,250 | ₩36,750 | 16,829 | |
| ₩37,100 | -100 | -0.3% | ₩37,200 | ₩37,500 | ₩36,900 | 8,365 | |
| ₩37,200 | +300 | +0.8% | ₩37,000 | ₩37,250 | ₩36,750 | 7,910 | |
| ₩36,900 | +50 | +0.1% | ₩36,900 | ₩37,000 | ₩35,750 | 6,064 | |
| ₩36,850 | +500 | +1.4% | ₩36,600 | ₩37,050 | ₩35,900 | 8,921 | |
| ₩36,350 | -1,250 | -3.3% | ₩37,550 | ₩37,550 | ₩35,600 | 28,485 | |
| ₩37,600 | +100 | +0.3% | ₩37,700 | ₩38,450 | ₩37,200 | 33,155 |
- Ticker
- KRX:145720
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · May 12, 2026
Dentium: Operating profit jumped 65% year-over-year despite a 7% revenue decline, driven by cost efficiency
Latest news
Dentium: Operating profit jumped 65% year-over-year despite a 7% revenue decline, driven by cost efficiency
May 12, 2026
Closed ₩53,200 (+5.3%) on May 13, 2026
Dentium: Revenue and profit declined sharply, but export focus and SOFC investments support long-term growth
Mar 23, 2026
Closed ₩49,300 (-6.6%) on Mar 23, 2026
Dentium To Cancel 79.4 Billion Won Worth Of Own Shares
Mar 4, 2026
Closed ₩50,400 (+14.3%) on Mar 5, 2026
Dentium: 4Q25 saw revenue drop 8% YoY and a net loss from one-off overseas asset impairment
Mar 3, 2026
Closed ₩44,100 (-9.4%) on Mar 4, 2026
Dentium Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 4 in the last 12 months · 11 in all · newest May 12, 2026 · oldest 2024
Valuation
P/E 10.8× against a median of 15.6×: 3rd lowest of 5 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩302.7B KRW
- P/E
- 10.8×
- EV/sales
- 0.9×
- EV/EBITDA
- 3.1×
- Price/book
- 0.6×
- Gross margin
- 65.6%
- Operating margin
- 20.0%
- Net margin
- 8.6%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Dentium Co., Ltd. · KRX:145720 | US$242.5M | US$224.9M | 10.8× | 0.9× | 3.1× | 0.6× | 8.6% | 0.1× | n/a |
| PT Jayamas Medica Industri Tbk · IDX:OMED | US$257.3M | US$192.4M | 10.5× | 1.4× | 6.4× | 1.6× | 18.2% | 0.1× | n/a |
| SS Innovations International Inc. · NASDAQ:SSII | US$254.7M | US$264.8M | n/a | 5.8× | n/a | 5.1× | −31.5% | 0.4× | 0.89 |
| Orthofix Medical Inc. · NASDAQ:OFIX | US$247.4M | US$382.9M | n/a | 0.5× | 11.8× | 0.6× | −5.4% | 0.5× | 1.09 |
| Profound Medical Corp · TSX:PRN | US$235.4M | US$206.6M | n/a | 8.7× | n/a | 5.5× | −137.5% | 0.1× | 1.19 |
| Jiangsu Nanfang Medical Co., Ltd. Class A · SSE:603880 | US$232.5M | US$234.0M | n/a | 2.8× | n/a | 10.4× | −18.9% | 0.3× | n/a |
| Jenscare Scientific Co. Ltd. Class H · HKEX:9877 | US$224.5M | US$168.2M | n/a | 12.7× | n/a | 2.0× | −299.4% | 0.1× | n/a |
| ClearPoint Neuro Inc. · NASDAQ:CLPT | US$221.5M | US$226.2M | n/a | 5.0× | n/a | 8.1× | −79.4% | 1.9× | 1.97 |
| Utah Medical Products, Inc. · NASDAQ:UTMD | US$220.6M | US$135.6M | 20.7× | 3.9× | n/a | 1.8× | 30.5% | 0.0× | 0.31 |
| JVM Co., Ltd. · KRX:054950 | US$219.0M | US$106.5M | 9.6× | 0.8× | 3.4× | 1.2× | 17.4% | 0.0× | n/a |
| Stille AB · OMXSTO:STIL | US$217.8M | US$201.1M | 23.1× | 2.9× | n/a | 2.8× | 13.5% | 0.0× | n/a |
| Median of the others | US$228.5M | US$203.8M | 15.6× | 3.4× | 6.4× | 2.4× | −12.1% | 0.1× | 1.09 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- Price target
- 67500.00 KRW · Analysts' mean
- EPS, year to Dec 2026
- 5007.33 · 3 analysts
- Revenue, year to Dec 2026
- 348.9B · 2 analysts
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Feb 26, 2026 · Before open | −1.4% |
| Q3 2025 | Nov 12, 2025 · Before open | +0.7% |
| Q2 2025 | Aug 12, 2025 · Before open | −1.0% |
| Q1 2025 | May 8, 2025 · Before open | +6.9% |
| Q4 2024 | Feb 26, 2025 · After close | −1.7% |
| Q3 2024 | Nov 7, 2024 · Before open | −1.8% |
| Q2 2024 | Aug 8, 2024 · Before open | −0.7% |
| Q1 2024 | May 9, 2024 · After close | −8.4% |
| Q4 2023 | Feb 28, 2024 · Before open | +5.9% |
| Q3 2023 | Nov 8, 2023 · Before open | +2.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Aug 8, 2023 · Before open | −0.5% |
| Q1 2023 | May 9, 2023 · After close | +6.3% |
| Q4 2022 | Feb 28, 2023 · Before open | +0.9% |
| Q3 2022 | Nov 8, 2022 · Before open | +5.2% |
| Q2 2022 | Aug 8, 2022 · Before open | 0.0% |
| Q1 2022 | May 9, 2022 · Before open | −5.2% |
| Q4 2021 | Mar 2, 2022 · After close | +20.4% |
| Q3 2021 | Nov 4, 2021 · Before open | +0.7% |
| Quarter to Jun 30, 2021 | Aug 10, 2021 · Before open | −2.0% |
| Quarter to Mar 31, 2021 | May 17, 2021 · Before open | −0.5% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 346.5B | 407.8B | 393.2B | 355.9B | 291.5B | 229.7B | 252.6B | 186.3B | 150.6B | 120.0B |
| Cost of revenue | 128.4B | 147.6B | 114.3B | 95.2B | 98.4B | 87.0B | 85.0B | 55.5B | 44.0B | 36.7B |
| Gross profit | 218.1B | 260.3B | 278.8B | 260.7B | 193.2B | 142.8B | 167.6B | 130.8B | 106.6B | 83.3B |
| Research and development | 5.59B | 7.65B | 6.87B | 5.63B | 5.45B | 5.02B | 6.51B | 8.40B | 5.25B | 4.68B |
| Selling, general and administrative | 62.7B | 76.4B | 64.6B | 57.0B | 58.2B | 40.3B | 53.1B | 38.8B | 27.4B | 19.9B |
| Operating income | 64.1B | 98.5B | 138.3B | 125.7B | 70.2B | 39.6B | 44.7B | 42.0B | 41.1B | 28.5B |
| Depreciation and amortization | 25.2B | 23.2B | 20.9B | 18.9B | 13.2B | 14.8B | 13.4B | 4.99B | 4.89B | 3.96B |
| EBITDA | 89.3B | 121.7B | 159.2B | 144.7B | 83.4B | 54.4B | 58.1B | 47.0B | 46.0B | 32.5B |
| Interest expense | 10.7B | 9.58B | 7.43B | 6.79B | 6.08B | 8.03B | 5.16B | 1.38B | 0 | 0 |
| Income before tax | 23.1B | 93.9B | 134.5B | 118.4B | 74.7B | 26.1B | 33.6B | 42.0B | 35.9B | 26.4B |
| Income tax | 19.2B | 3.83B | 19.9B | 7.75B | 5.59B | 6.39B | ||||
| Net income | 16.4B | 72.7B | 96.5B | 86.1B | 55.5B | 22.5B | 14.8B | 34.3B | 30.1B | 19.8B |
| Earnings per share, basic | 1,902.94 | 8,431.24 | 11,192.65 | 9,979.97 | 6,433.76 | 2,614.22 | 1,714.50 | 3,971.91 | 3,486.41 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 77.1B | 99.6B | 86.9B | 72.1B | 65.8B | 37.3B | 28.1B | 21.8B | 53.2B | 9.06B |
| Short-term investments | 11.5B | 10.2B | 150.0M | 1.73B | 1.70B | 2.24B | 1.50B | |||
| Receivables | 142.2B | 164.9B | 135.4B | 108.6B | 83.4B | 92.4B | 117.7B | 93.2B | 57.7B | 52.5B |
| Inventory | 204.4B | 148.2B | 127.0B | 100.8B | 76.1B | 55.6B | 66.7B | 46.4B | 34.9B | 25.9B |
| Current assets | 456.1B | 476.6B | 370.6B | 303.7B | 240.3B | 195.3B | 225.8B | 169.9B | 149.2B | 92.0B |
| Property, plant and equipment | 273.1B | 267.5B | 278.3B | 247.4B | 150.1B | 84.1B | ||||
| Goodwill | 0 | 0 | 102.1M | 103.0M | 183.3M | 203.1M | 249.9M | 0 | 0 | |
| Total assets | 932.8B | 894.4B | 773.8B | 674.6B | 570.2B | 510.2B | 547.1B | 436.8B | 310.9B | 187.4B |
| Accounts payable | 14.9B | 11.9B | 13.3B | 10.1B | 9.98B | 8.28B | 12.5B | 8.06B | 5.76B | 5.19B |
| Current liabilities | 317.8B | 293.3B | 263.0B | 229.3B | 180.2B | 193.3B | 174.7B | 140.4B | 97.1B | 96.1B |
| Long-term debt | 46.8B | 42.6B | 41.9B | 66.3B | 95.2B | 82.9B | 158.9B | 99.3B | 49.7B | 19.9B |
| Total liabilities | 371.6B | 340.9B | 309.9B | 301.4B | 279.1B | 281.6B | 340.6B | 242.1B | 148.4B | 117.9B |
| Shareholders' equity | 562.4B | 554.7B | 464.6B | 373.9B | 291.8B | 229.3B | 206.9B | 194.1B | 161.9B | 69.0B |
| Shares outstanding | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M | 8.62M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 13.2B | 36.5B | 65.0B | 47.0B | 74.1B | 75.8B | -11.6B | -574.6M | 21.7B | 17.6B |
| Capital spending | -53.6B | -21.7B | -44.1B | -54.1B | -28.2B | -8.62B | -51.3B | -107.4B | -72.3B | -19.0B |
| Free cash flow | -40.3B | 14.8B | 20.8B | -7.10B | 45.1B | 66.7B | -64.1B | -109.4B | -51.4B | -1.39B |
| Cash from investing | -21.8B | -9.25B | -56.0B | -111.8B | -73.9B | -19.1B | ||||
| Cash from financing | -24.1B | -50.0B | 74.6B | 80.2B | 96.4B | 5.22B | ||||
| Dividends paid | -5.17B | -3.45B | -2.59B | -2.16B | -1.72B | -1.72B | -1.29B | -1.29B | -607.8M | -607.8M |
| Change in cash | -22.5B | 12.7B | 14.9B | 6.21B | 28.5B | 9.20B | 6.35B | -31.4B | 44.1B | 3.73B |
Cap table
Built by 6ix from Dentium Co., Ltd.’s releases
- Common shares
- 8,264,884
- Fully diluted
- 8,264,884
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 8,264,884 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 8,264,884 |
Log in to ask 6ix AI your own questions about Dentium Co., Ltd.